The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa

Abstract

Data on IRS suggest that HS may be more prevalent than previously suggested, and the prevalence may be comparable to other major dermatoses, e.g. psoriasis. However, as no physician examination was done, the risk of recall and information bias is a major limitation.

Hidradenitis Suppurativa in General Practice: A Pilot Study

“…HS has been considered to be a rare disorder but European studies based on population samples using validated questionnaires have suggested a prevalence of 1%-2% in the general population and a peak prevalence of 4% (including mild cases) among young adults [4][5][6][7][8].…”

Epidemiology of hidradenitis suppurativa in Poland in relation to international data

“…Also, most experts concur that the maximum duration of the active form of HS in a given patient is about 20 years [6]. With regard to the estimated prevalence of the disease in European countries and in the United States, available data differ by up to four orders of magnitude, ranging from 0.00033% to 4.1% [7][8][9][10][11][12][13][14][15][16][17][18].…”

“…Więk-szość ekspertów jest również zgodna, że czas trwania czynnej postaci HS wynosi u danego pacjenta maksymalnie ok. 20 lat [6]. Dane dotyczące częstości wystę-powania choroby w krajach europejskich i USA różnią się nawet o 4 rzędy wielkości i mieszczą się w przedziale od 0,00033% do 4,1% [7][8][9][10][11][12][13][14][15][16][17][18].…”

Coagulation Status in Hidradenitis Suppurativa: A Danish Population- and Hospital-Based Cross-Sectional Study

“…axilla, inguinal and anogenital areas [1]. Recent studies indicate a prevalence of 2.1% in the general population [2] and a rising incidence [3], making it a not uncommon skin disease.…”